Gmax BioPharm looking to enter competitive PAH market with early stage drug GMA301
In preclinical testing on animal models, GMA301 showed improved efficacy in lowering right ventricular pressure and hypertrophy,…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.